There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Draegerwerk AG & Co. KGaA (GB:0K5E – Research Report) and Novartis AG (CH:NOVN – Research Report) with bullish sentiments.
Draegerwerk AG & Co. KGaA (GB:0K5E)
In a report released yesterday, Christian Ehmann from Warburg Research reiterated a Buy rating on Draegerwerk AG & Co. KGaA, with a price target of EUR53.10. The company’s shares closed yesterday at EUR46.02.
According to TipRanks.com, Ehmann is ranked #7899 out of 8514 analysts.
Currently, the analyst consensus on Draegerwerk AG & Co. KGaA is a Moderate Buy with an average price target of EUR51.37.
See the top stocks recommended by analysts >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
